Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/20/26 17:05 | 2/18/26 | LXEO | Health | BioPrd | Biological Products, (No Diag | Otero Jose Manuel | NY | O | COO | 5 | S | -65 | 6.89 | 0 | -9 | 125 | D | |||||||||||||||
2/20/26 17:05 | 2/18/26 | LXEO | Health | BioPrd | Biological Products, (No Diag | Townsend Richard Nolan | NY | DO | CEO | 9 | S.d | -273 | 7.05 | 0 | -39 | 392 | D | |||||||||||||||
11/20/25 17:20 | 11/18/25 | LXEO | Health | BioPrd | Biological Products, (No Diag | Adler Eric | NY | O | Chief Me | 5 | S | -51 | 6.73 | 0 | -8 | 73 | D | |||||||||||||||
11/20/25 17:19 | 11/18/25 | LXEO | Health | BioPrd | Biological Products, (No Diag | See Tai Sandi | NY | O | Chief De | 5 | S | -48 | 7.33 | 0 | -7 | 66 | D | |||||||||||||||
11/20/25 17:18 | 11/18/25 | LXEO | Health | BioPrd | Biological Products, (No Diag | Robertson Jenny | NY | O | GC | 5 | S | -50 | 6.89 | 0 | -7 | 69 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |